Where does New England Biolabs, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), New England Biolabs, Inc. ranks #2,974 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does New England Biolabs, Inc. hold?

New England Biolabs, Inc. holds 128 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is New England Biolabs, Inc.'s Innovation Score?

New England Biolabs, Inc. has an Innovation Score of 48.2 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is New England Biolabs, Inc.'s patent grant rate increasing or decreasing?

New England Biolabs, Inc.'s recent grant velocity is -21% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for New England Biolabs, Inc.'s patents?

New England Biolabs, Inc.'s patents average 15.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the New England Biolabs, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

New England Biolabs, Inc.

Q: What technology areas does New England Biolabs, Inc. focus on?

New England Biolabs, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 101 patents, ranking #85 of 4,144 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

USPTO PatentsView assignee record - 128 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, New ranks #2,974 of 49,997 tracked US assignees by granted-patent volume, with 128 patents across 18 technology areas.

#2,974
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.2/100): 15.5
avg claims per patent: -21%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2974 · US Corporation #2,974 · 128 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 128 grants
TOP-DECILE #2,974/49,997
PHOTO-FINISH Luminar
CPC-FOCUS C12N · 18 areas
INNOV-PAR 48.2/100
CLAIMS-RICH 15.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -21% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Luminar Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How New’s 48.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.8 pts (35%) Velocity 7.1 pts (15%) Breadth 15.0 pts (31%) Claim depth 9.3 pts (19%)

Qualcomm Incorporated · highest

85
Tianma Japan · near

48
Asahi Kasei Medical · near

48
Gachon University… · near

48
New England Biolabs · this assignee

48
Soonchunhyang… · near

48
3D Lighting… · lowest

7

What this shows New's Innovation Score is 48.2/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for New?

Each dot is one of New’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). New’s own 15.5 claims/patent is at or below the 16.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

New vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where New's grants concentrate

New England Biolabs, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 78.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2015 (26 grants) versus a trough of 6 in 2017. By volume, New sits between Luminar Technologies, Inc. and TK Holdings, LLC.

New's three-year grant acceleration

From 2019–2021 to 2022–2024, New England Biolabs, Inc. moved from 33 to 35 grants (1.06x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,038. See the growth leaderboard.

Luminar

128
Microtech Knives

128
NCR Voyix

128
Netease (Hangzhou…

128
Radio Systems

128
Resonant

128
Shanghai Bilibili…

128
TK Holdings

128
New England Biola… ◀

128

What this shows New holds 128 patents at rank #2,974, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near New

By rank, the assignees closest to #2,974 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in New's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for New, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), New ranks #85 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Gachon University of Industry-Academic Cooperation Foundation 48 Asahi Kasei Medical Co., Ltd. 48 Soonchunhyang University Industry Academy Cooperation Foundation 48 Tianma Japan, Ltd. 48

Similar claim depth

Nearest assignees by average claims per patent (15.5 here).

Bolton Medical, Inc. 15.5 avg Honda Research Institute Europe GmbH 15.5 avg Nanoco Technologies, Ltd. 15.5 avg ColdQuanta, Inc. 15.5 avg

New's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

New England Biolabs, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	26	20.3%
2016	9	7.0%
2017	6	4.7%
2018	16	12.5%
2019	13	10.2%
2020	8	6.3%
2021	12	9.4%
2022	16	12.5%
2023	10	7.8%
2024	9	7.0%
2025partial year	3	2.3%

Which technologies does New England Biolabs, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 101

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 88

C12Y - Enzymes 62

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 33

C07K - Peptides 24

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 19

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 9

Y02A - Technologies FOR Adaptation TO Climate Change 5

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 5

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 3

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 2

C07D - Heterocyclic Compounds 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

New England Biolabs, Inc.'s patent record in context - here's where to go next.

New England Biolabs, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 78.9% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #2,974 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare New England Biolabs, Inc. against Luminar Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.